Table 2.
Clinical Characteristics of Each Mood Episode
Total n=775 | Mood Episode | ||||
---|---|---|---|---|---|
Remission n=398 | Depressive Episode n=268 | Manic Episode n=50 | Mixed Episode n=59 | ||
Sex, male(%) | 65% | 67% | 69% | 54% | 47% |
Age(SD) | 44.4(8.9) | 44.4(9.0) | 44.3(8.7) | 46.0(8.5) | 43.6(8.8) |
Psychiatric comorbidity | 17% | 14% | 15% | 22% | 36% |
Physical comorbidity | 25% | 21% | 25% | 32% | 46% |
Rapid cycling | 9% | 6% | 9% | 12% | 21% |
Psychotic symptom | 5% | 5% | 6% | 4% | 8% |
Suicide ideation | 7% | 0% | 15% | 0% | 22% |
Substance abuse | 5% | 3% | 8% | 6% | 12% |
Mood stabilizer prescriptions | |||||
0 | 16% | 12% | 21% | 10% | 20% |
1 | 64% | 69% | 57% | 62% | 64% |
2 | 18% | 16% | 21% | 28% | 12% |
3 or more | 2% | 2% | 1% | 0% | 3% |
Lithium | 47% | 50% | 44% | 56% | 36% |
Valproic acid | 27% | 26% | 25% | 36% | 37% |
Carbamazepine | 3% | 3% | 3% | 6% | 3% |
Lamotrigine | 28% | 28% | 31% | 20% | 22% |
Antipsychotics prescriptions | |||||
0 | 53% | 57% | 46% | 64% | 44% |
1 | 38% | 34% | 41% | 30% | 53% |
2 | 10% | 9% | 13% | 6% | 3% |
3 or more | 0% | 0% | 0% | 0% | 0% |
Aripiprazole | 11% | 10% | 12% | 6% | 17% |
Olanzapine | 21% | 18% | 25% | 14% | 19% |
Quetiapine | 11% | 10% | 13% | 6% | 10% |
Risperidone | 2% | 2% | 2% | 6% | 2% |
Antidepressant prescriptions | |||||
0 | 56% | 65% | 42% | 75% | 55% |
1 | 34% | 29% | 46% | 19% | 44% |
2 | 9% | 7% | 11% | 6% | 2% |
3 or more | 1% | 0% | 1% | 0% | 0% |
Anxiolytics prescriptions | |||||
0 | 65% | 72% | 54% | 72% | 64% |
1 | 31% | 25% | 40% | 26% | 34% |
2 | 4% | 3% | 5% | 2% | 2% |
3 or more | 0% | 0% | 0% | 0% | 0% |
Hypnotics prescriptions | |||||
0 | 46% | 54% | 38% | 40% | 36% |
1 | 34% | 29% | 38% | 34% | 46% |
2 | 19% | 16% | 22% | 26% | 19% |
3 or more | 1% | 1% | 1% | 0% | 0% |
Bipolar Disorder Subcategories | |||||
Type I | 25% | 27% | 20% | 34% | 27% |
Type II | 69% | 67% | 75% | 62% | 63% |
Unclassifiable | 6% | 5% | 6% | 4% | 10% |
Abbreviation: SD, standard deviation.